Clinical Trials Logo
  1. Home
  2. Diabetes Mellitus, Type 2
  3. NCT05915338

Training on Using ıInsulin in Patients With Type 2 Diabetes — INSÜLIN  

Diabetes type2 Clinical Trial

Official title:
The Eof ıInsulin Use Education on Safe Drug Administration, Pain Level and Perception of Treatment in Patients With Type 2 Diabetes

Clinical Trial Summary

This study was conducted to evaluate the effect of individual insulin use training given to patients with type 2 diabetes using insulin on safe drug administration, pain level and perception of treatment. The study was conducted between October 2022 and March 2023 with a randomized control group.

Clinical Trial Description

Objective: The aim of this study was to examine the effects of individual insulin use training given to patients with Type 2 diabetes on safe drug administration, pain level and treatment perception, and to contribute to both national and international literature. Method: It was conducted between October 2022 and March 2023 as a randomized controlled study in a pre-test-post-test order to determine the effect of individual insulin use education given to patients with type 2 diabetes on safe drug administration, pain level and treatment perception. The data were collected by the researchers with the descriptive information form of the patients, the Insulin Administration Skill Observation Form, the Visual Analogue Scale and the Insulin Therapy Evaluation Scale. Data Collection: Face-to-face and individual interviews with patients who applied to the Internal Diseases and Endocrinology Polyclinic and Diabetes Nursing Polyclinics of a state hospital in a city located in the Southeastern Anatolia Region of Turkey, and who were hospitalized in the Internal Diseases, Endocrinology, Physical Therapy and Rehabilitation and Cardiology Services. collected using the method. A pilot study was not conducted before starting the study. Before the study, all patients were informed about the study and their verbal and written consents were obtained. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05915338
Study type Observational [Patient Registry]
Source Inonu University
Contact
Status Completed
Phase
Start date October 1, 2022
Completion date March 30, 2023
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04164602 - The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly
Not yet recruiting NCT04998461 - Impact of Obesity, Chronic Kidney Disease and Type 2 Diabetes on Human Urinary Stem Cells
Not yet recruiting NCT04880005 - Digital Individualized and Collaborative Treatment of T2D in General Practice Based on Decision Aid N/A
Recruiting NCT05365529 - Time-Restricted Eating for Type II Diabetes: TRE-T2D N/A
Recruiting NCT03958591 - Effects of Short-term Intensive De-escalation Therapy on Long-term Regimen Simplification Phase 4
Completed NCT05284071 - Actiste® Diabetes Management as a Service (ADMS) Clinical Investigation N/A
Recruiting NCT05501093 - Diabetes Reversal and the Subgingival Microbiota
Active, not recruiting NCT05784220 - The Canadian Diabetes Prevention Program N/A
Active, not recruiting NCT04286555 - Dietary Approaches to Stop Hypertension for Diabetes N/A
Completed NCT05076656 - Epigenetic and Microbiota Modifications Early Phase 1
Completed NCT04423302 - Effect of Totum-63 on Glucose and Lipid Homeostasis in Subjects With Dysglycemia (REVERSE-IT) N/A
Completed NCT05928637 - A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of D745, D759, and D150 Phase 1
Active, not recruiting NCT04660630 - A Real World Research: Comparison of Precision and Experience Therapy for Hypertension, Diabetes or Hyperlipidemias N/A
Recruiting NCT03435328 - Hyposalivation Response To Transcutaneous Electrical Nerve Stimulation In Diabetic Type 2 Patients N/A
Recruiting NCT04447859 - 16-week Flexible vs. 8-week Semaglutide Titration Phase 3
Not yet recruiting NCT03968354 - NASH and Type 2 Diabetes: Role of the Receptor Activator of Nuclear Factor-κB (RANK) and Its Ligand (RANKL)
Terminated NCT04819256 - Primary Care Based Integrated Community Care Team Intervention N/A
Recruiting NCT05629221 - Organisational Models Supported by Technology for the Management of Diabetic Disease and Its Complications in a Diabetic Clinic Setting. A Randomised Controlled Trial Targeting Type 2 Diabetes Individuals With Non-ideal Glycemic Values N/A
Completed NCT05260983 - Acceptance and Commitment Therapy Principles for Diabetes Prevention N/A